advertisement
CuraGen initiated with "buy"
11/14/06 - BWS Financial
NEW YORK, November 14 (newratings.com) - Analysts at BWS Financial initiate coverage of CuraGen Corporation (CRGN) with a "buy" rating. The target price is set to $8.
News